These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 10404696)

  • 1. Risk factors of renal failure progression two years prior to dialysis.
    Mazouz H; Kacso I; Ghazali A; El Esper N; Moriniere P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
    Clin Nephrol; 1999 Jun; 51(6):355-66. PubMed ID: 10404696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factors in the progression of renal insufficiency during the 2 years preceding the use of dialysis].
    Kacso I; Gherman M; Mazouz H; Ghazali A; el Esper N; Morinière P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
    Nephrologie; 1999; 20(1):19-28. PubMed ID: 10081033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression rate to end-stage renal failure in non-diabetic kidney diseases: a multivariate analysis of determinant factors.
    Jungers P; Hannedouche T; Itakura Y; Albouze G; Descamps-Latscha B; Man NK
    Nephrol Dial Transplant; 1995; 10(8):1353-60. PubMed ID: 8538926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of outcome in Henoch-Schönlein nephritis in children and adults.
    Coppo R; Andrulli S; Amore A; Gianoglio B; Conti G; Peruzzi L; Locatelli F; Cagnoli L
    Am J Kidney Dis; 2006 Jun; 47(6):993-1003. PubMed ID: 16731294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure.
    Williams PS; Fass G; Bone JM
    Q J Med; 1988 Apr; 67(252):343-54. PubMed ID: 3205906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experience in the use of valsartan with the aim to inhibit progression of kidney failure in patients with chronic glomerulonephritis].
    Shvetsov MIu; Medvedeva TIu; Kozlovskaia NL; Miroshnichenko NG; Okonova EB; Shonichev DG; Rudenko TE; Stavrovskaia EV; Plieva OK
    Ter Arkh; 2001; 73(6):55-61. PubMed ID: 11521525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial.
    Williams PS; Stevens ME; Fass G; Irons L; Bone JM
    Q J Med; 1991 Oct; 81(294):837-55. PubMed ID: 1801057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting chronic renal failure progression: results from a multicentre trial. The Northern Italian Cooperative Study Group.
    Locatelli F; Alberti D; Graziani G; Buccianti G; Redaelli B; Giangrande A; Marcelli D; Francucci BM
    Miner Electrolyte Metab; 1992; 18(2-5):295-302. PubMed ID: 1465079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting progression in advanced chronic renal failure.
    Hannedouche T; Chauveau P; Kalou F; Albouze G; Lacour B; Jungers P
    Clin Nephrol; 1993 Jun; 39(6):312-20. PubMed ID: 8334758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history of chronic renal failure: a reappraisal.
    Wight JP; Salzano S; Brown CB; el Nahas AM
    Nephrol Dial Transplant; 1992; 7(5):379-83. PubMed ID: 1321371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinuria in mild to moderate hypertension: results of the VA cooperative study of six antihypertensive agents and placebo. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.
    Preston RA; Materson BJ; Reda DJ; Hamburger RJ; Williams DW; Smith MH
    Clin Nephrol; 1997 May; 47(5):310-5. PubMed ID: 9181278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of initial blood pressure on the mortality of diabetics undergoing renal replacement therapy.
    Abderrahim E; Zouaghi K; Kheder A; Cherif M; Boubaker K; Mahfoudhi M; Hedri H; Ounissi M; Ben Hamida F; Ben Moussa F; Ben Abdallah T; El Younsi F; Kâaroud H; Béji S; Goucha R; Ben Maïz H
    Transplant Proc; 2004; 36(6):1820-3. PubMed ID: 15350486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialyzer membrane permeability and survival in hemodialysis patients.
    Chauveau P; Nguyen H; Combe C; Chêne G; Azar R; Cano N; Canaud B; Fouque D; Laville M; Leverve X; Roth H; Aparicio M;
    Am J Kidney Dis; 2005 Mar; 45(3):565-71. PubMed ID: 15754279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.
    Iseki K; Kinjo K; Iseki C; Takishita S
    Am J Kidney Dis; 2004 Nov; 44(5):806-14. PubMed ID: 15492946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.